Economic evaluation of sustained sedation/analgesia in the intensive care unit

Expert Opinion on Pharmacotherapy

Volumn 7, Issue 15, 2006, Pages 2047-2068

  MacLaren, Robert ^a   Sullivan, Patrick W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Adverse event; Analgesia; Assessment; Awakening; Benzodiazepine; Complication; Cost; Critical care; Intensive care; Propofol; Protocol; Sedation

Indexed keywords

HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT;

CONSCIOUS SEDATION; COST CONTROL; ECONOMICS; EXPERT WITNESS; HUMAN; INTENSIVE CARE UNIT; REVIEW; STATISTICAL MODEL; STATISTICS;

ANALGESICS, OPIOID; CONSCIOUS SEDATION; COST CONTROL; EXPERT TESTIMONY; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; MODELS, ECONOMIC;

EID: 33750137532     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.7.15.2047     Document Type: Review

References (155)

1. JACOBI J, FRASER GL, COURSIN DB et al.: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit. Care Med. (2002) 30:119-141. •• Multidisciplinary consensus recommendations for the use of sedatives and analgesics, and the monitoring of sedation and analgesia in critically ill patients. (Pubitemid 34112188)
2. KRESS JP, POHLMAN AS, HALL JB: Sedation and analgesia in the intensive care unit. Am. J. Respir. Crit. Care Med. (2002) 166:1024-1028. (Pubitemid 35178698)
3. VENDER JS, SZOKOL JW, MURPHEY GS, NITSUN M: Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based approach. Crit. Care Med. (2004) 32:S554-S561. (Pubitemid 39489029)
4. YOUNG C, KNUDSEN N, HILTON A, REVES JG: Sedation in the intensive care unit. Crit. Care Med. (2000) 28:854-866. (Pubitemid 30174290)
5. ALSARRAF AA, FOWLER R: Health, economic evaluation, and critical care. J. Crit. Care (2005) 20:194-197. (Pubitemid 41219645)
6. DASTA JF, MCLAUGHLIN TP, MODY SH, PIECH CT: Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit. Care Med. (2005) 33:1266-1271. (Pubitemid 40827376)
7. KRESS JP, HALL JB: Cost considerations in sedation, analgesia, and neuromuscular blockade in the intensive care unit. Sem. Respir. Crit. Care Med. (2001) 22:199-209. (Pubitemid 32729513)
8. COSMOS A, JANECSKO M, EDBROOKE D: Comparative costing analysis of intensive care services between Hungary and United Kingdom. Intensive Care Med. (2005) 31:1280-1283. (Pubitemid 41355807)
9. AL-HADDAD M, HAYWARD I, WALSH TS: A prospective audit of cost of sedation, analgesia and neuromuscular blockade in a large British ICU. Anaesthesia (2004) 59:1121-1125. (Pubitemid 39429878)
10. ARROLIGA A, FRUTOS-VIVA F, HALL J et al.: Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest (2005) 128:496-506. (Pubitemid 41140473)
11. MURDOCH S, COHEN A: Intensive care sedation: review of current British practice. Intensive Care Med. (2000) 26:922-928. (Pubitemid 30616045)
12. BERTOLINI G, MELOTTI R, ROMANO P et al.: Use of sedative and analgesic drugs in the first week of ICU stay: a pharmacoepidemiological perspective. Minerva Anesthesiol. (2001) 67:96-105.
13. SOLIMAN HM, MELOT C, VINCENT JL: Sedative and analgesics practice in the intensive care unit: the results of a European survey. Br. J. Anaesth. (2002) 87:186-192.
14. MARTIN J, PARSCH A, FRANCK M, WERNECKE KD, FISCHER M, SPIES C: Practice of sedation and analgesia in German intensive care units: results of a national survey. Crit. Care (2005) 9:R117-R1123.
15. EGEROD I, CHRISTENSEN BV, JOHANSEN L: Trends in sedation practices in Danish intensive care units in 2003: a national survey. Intensive Care Med. (2006) 32:60-66.
16. SAMUELSON KA, LARSSON S, LUNDBERG D, FRIDLUND B: Intensive care sedation of mechanically ventilated patients: a national survey. Intensive Crit. Care Nurs. (2003) 19:350-362. (Pubitemid 37527662)
17. WATLING SM, DASTA JF, SEIDL EC: Sedatives, analgesics and paralytics in the ICU. Ann. Pharmacother. (1997) 31:148-153. (Pubitemid 27074098)
18. MEHTA S, BURRY L, FISCHER S et al.: Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit. Care Med. (2006) 34:374-380. • A comprehensive survey of sedation practices in Canada that found all agents are commonly used, but practices of daily awakening, sedation monitoring and protocols were only occasionally used. (Pubitemid 43145615)
19. DEVLIN JW, TANIOS MA, EPSTEIN SK: Current practices, beliefs and attitudes on sedation in the intensive care unit using a large scale national survey. Crit. Care Med. (2004) 32(Suppl.):A70. Abstract.
20. TANIOS MA, DEVLIN JW, EPSTEIN SK: Perceived barriers to implementing strategy of daily interruption of sedation in the intensive care unit for critically ill patients. Am. J. Respir. Crit. Care Med. (2005) 171:A793. Abstract.
21. CARRASCO G, MOLINA R, COSTA J, SOLER JM, CABRE L: Propofol versus midazolam in short-, medium-, and long-term sedation of critically ill patients. Chest (1993) 103:557-564. • A randomised study of midazolam and propofol assessing sedation-related costs relative to the duration of therapy in medical and surgical ICUs. This study found that propofol is less costly for short-term sedation, but costs are equivalent for intermediate- and long-term sedation because the high acquisition cost of propofol outweighs its clinical benefit of earlier extubation. (Pubitemid 23070763)
22. CARRASCO G, CABRE L, SOBREPERE G et al.: Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery grafting. Crit. Care Med. (1998) 26:844-851. • A short-term sedation study of patients after coronary artery bypass grafting, demonstrating synergistic sedation with midazolam and propofol resulting in reduced sedative costs. (Pubitemid 28211394)
23. HALL RI, SANDHAM D, CARDINAL P et al.: Propofol versus midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest (2001) 119:1151-1159. (Pubitemid 32679444)
24. ANIS AH, WANG X, LEON H, HALL R: Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology (2002) 96:196-201. • A randomised study of midazolam and propofol assessing sedation-related costs relative to the duration of therapy in medical and surgical ICUs that found that the agents have similar costs despite prolonged extubation with midazolam. (Pubitemid 34032501)
25. HIGGINS TL, YARED JP, ESTAFANOUS FG, COYLE JP, KO HK, GOODALE DB: Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting. Crit. Care Med. (1994) 23:1415-1423. (Pubitemid 24277986)
26. SEARLE NR, COTE S, TAILLEFER J et al.: Propofol or midazolam for sedation and early extubation following cardiac surgery. Can. J. Anaesth. (1997) 44:629-635. (Pubitemid 27412689)
27. COSTA J, CABRE L, MOLINA R, CARRASCO G: Cost of ICU sedation: comparison of empirical and controlled sedation methods. Clin. Intensive Care (1994) 5(Suppl.):17-21. • A cross-over study using midazolam in medical, surgical and trauma ICUs that showed assessing the depth of sedation reduced sedation-related costs.
28. OZSEZGIN S, GOKMEN N, ERDEM O, ARKAN A: Comparison of co-sedation with propofol + midazolam, propofol, and midazolam for sedation of patients undergoing mechanical ventilation in the ICU. Br. J. Anaesth. (1999) 82(Suppl.):165. Abstract.
29. BARRIENTOS-VEGA R, SANCHEZ-SORIA MM, MORALES-GARCIA C, ROBAS-GOMEZ A, CUENA-BOY R, AYENSA-RICON A: Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit. Care Med. (1997) 25:33-40. • A randomised study of midazolam and propofol for long-term sedation that assessed sedation-related costs in medical and surgical ICUs, and found that extubation was faster with propofol. (Pubitemid 27015036)
30. BARRIENTOS-VEGA R, SANCHEZ-SORIA MM, MORLAES-GARCIA C, CUENA-BOY R, CASTELLANO-HERNANDEZ M: Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit. Care Med. (2001) 29:317-322. (Pubitemid 32171776)
31. BERENYI T, MEZOFI M: Propofol versus midazolam for sedation in critically ill patients. Br. J. Anaesth. (1995) 74:113. Abstract.
32. MILLAN RJ, SOLBERG CL, TSCHIDA J, JOHNSON SV, HOEY LL, VANCE-BRYAN K: A comparison of propofol and midazolam for sedation in critically ill patients: a retrospective, matched, case-controlled, pilot study. Pharmacotherapy (1995) 15:370. Abstract.
33. SHWED-MCCOLLAM J, O'NEIL MG, NORCOSS ED, BYRNE TK, REEVES ST: Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit. Care Med. (1999) 27:2454-2458. •• A randomised study of lorazepam, midazolam and propofol for long-term sedation in surgical and trauma ICUs that found that lorazepam was the least-expensive agent, but this study only considered sedative costs.
34. WEINBROUM AA, HALPERN P, RUDICK V, SORKINE P, FREEDMAN M, GELLER E: Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med. (1997) 23:1258-1263. • A randomised study of midazolam and propofol for long-term sedation in medical, surgical and neurological ICUs, which found that midazolam to be less expensive without prolonging extubation. (Pubitemid 28017792)
35. KROSNER SM, LIN HM, NAGY K, JOSEPH K, FILDES J, ROBERTS R: Efficacy and cost: comparison of lorazepam and midazolam for continuous IV sedation in critically injured trauma patients. Crit. Care Med. (1994) 22:A54. Abstract.
36. SWART EL, STRACK VAN SCHIJNDEL RJ, VAN LOENEN AC, THIJS LG: Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit. Care Med. (1999) 27:1461-1465. • A randomised study of lorazepam and midazolam for long-term sedation in a medical ICU, which found lorazepam to be less expensive in terms of drug costs and was associated with adequate sedation. (Pubitemid 29406933)
37. TIERNEY M, SNELL CC, CARDINAL P, BAXTER A: Comparison of duration of mechanical ventilation and cost associated with midazolam and lorazepam infusions in critically ill patients. Can. J. Hosp. Pharm. (1996) 49:211-215. (Pubitemid 26333655)
38. AITKENHEAD AR, PEPPERMAN ML, WILLATTS SM et al.: Comparison of propofol and midazolam for sedation in critically ill patients. Lancet (1989) 11:704-709. (Pubitemid 19243114)
39. BOECKE A, LAUWERS J, SCHURINK G: A pilot study to compare the use of propofol and midazolam for long-term sedation. J. Drug Dev. (1989) 2(Suppl.):71-72. (Pubitemid 20045009)
40. BOYD O, MACKAY CJ, RUSHMER F, BENNETT ED, GROUNDS RM: Propofol or midazolam for short-term alterations in sedation. Can. J. Anesth. (1993) 40:1142-1147. (Pubitemid 24037505)
41. CHAUDRI S, KENNY GNC: Sedation after cardiac by-pass surgery: comparison of propofol and midazolam in the presence of a computerized closed loop arterial pressure controller. Br. J. Anaesth. (1992) 68:98-99.
42. CLARKE TN: Propofol compared with midazolam for sedation following prolonged neurosurgery. J. Drug Dev. (1991) 4(Suppl.):108-109.
43. COLLARD E, DELIRE V, MAYNE A et al.: Propofol-alfentanil versus fentanyl-midazolam in coronary artery surgery. J. Cardiothor. Vasc. Anesth. (1996) 10:869-876. (Pubitemid 26422480)
44. DU GRES B, FLAMENS C: A comparison of propofol and midazolam infusion for post operative sedation after cardiac surgery. J. Cardiothor. Surg. (1990) 4(Suppl.):101.
45. FARLING PA, JOHNSTON JR, COPPEL DL: Propofol infusion compared with morphine and midazolam bolus doses for sedation of patients with severe head injuries in the intensive care unit. J. Drug Dev. (1989) 2(Suppl.):97-98. (Pubitemid 20045018)
46. FRUH B: A comparison of propofol and midazolam for long-term sedation of ventilated patients: a cross-over study. J. Drug Dev. (1989) 2(Suppl.):45-47. (Pubitemid 20045001)
47. GROUNDS RM, LALOR JM, LUMLEY J, ROYSTON D, MORGAN M: Propofol infusion for sedation in the intensive care unit: preliminary report. Br. Med. J. (1987) 294:397-400. (Pubitemid 17023610)
48. HECHT U, LEHMKUHL P, PICHLMAYR I: Propofol for maintenance of sedation with EEG monitoring. J. Drug Dev. (1989) 2(Suppl.):41. (Pubitemid 20044999)
49. MARGGRAF G, BALZEREIT A, FRIEDRISH I, SCHONFELDER B, DOETSCH N, REIDMEISTER JC: Post-cardiac surgery sedation. Intensive Care Med. (1994) 20(Suppl.):S140. Abstract.
50. MCMURRAY TJ, COLLIER PS, CARSON IW, LYONS SM, ELLIOTT P: Propofol sedation after open-heart surgery. Anaesthesia (1990) 45:322-326.
51. ROEKAERTS PMJH, HUYGEN FJ, DELANGE S: Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery. J. Cardiothor. Vasc. Anesth. (1993) 7:142-147. (Pubitemid 23111800)
52. RONAN KP, GALLAGHER TJ, GEORGE B, HAMBLY B: Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit. Care Med. (1995) 23:286-293.
53. SNELLEN F, LAUWERS P, DEMEYERE R, BYTTEBIER G, VAN AKEN H: The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting. Intensive Care Med. (1990) 16:312-316. (Pubitemid 20253467)
54. WOLFS C, KIMBIMBI L, COLIN L, NOEL F, NEUBERG D: A comparison of propofol/fentanyl and midazolam/fentanyl for ICU sedation after abdominal surgery. J. Drug Dev. (1990) 4(Suppl.):69-71.
55. BOYLE WA, SHEAR JM, WHITE PF, SCHULLER D: Long-term sedative infusion in the intensive care unit: propofol versus midazolam. J. Drug Dev. (1991) 4(Suppl.):43-45.
56. GLEW RC: Long-term intensive care sedation: a comparison of propofol and midazolam. J. Drug Dev. (1989) 2(Suppl.):55-56. (Pubitemid 20045004)
57. KRESS JP, O'CONNOR MF, POHLMAN AS et al.: Sedation of critically ill patients during mechanical ventilation: a comparison of propofol and midazolam. Am. J. Resp. Crit. Care Med. (1996) 153:1012-1018. (Pubitemid 126424918)
58. SEYDE WC, BEYER R, BUSSE C et al.: Long-term sedation in the intensive care unit: a comparison of propofol and midazolam. J. Drug Dev. (1989) 2(Suppl.):79-80. (Pubitemid 20045013)
59. BEYER R, SEYDE WC: Long-term sedation (24h) in the intensive care unit: a comparison of propofol and midazolam. J. Drug Dev. (1991) 4(Suppl.):67-68.
60. CHAMORRO C, DELATORRE FJ, MONTERO A et al.: Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicentre trial. Crit. Care Med. (1996) 24:932-939. (Pubitemid 26189932)
61. DEGAUQUE C, DUPUIS A: A study to compare the use of propofol and midazolam for the sedation of patients with acute respiratory failure. J. Drug Dev. (1991) 4(Suppl.):95-97.
62. KRESS JP, POHLMAN AS, O'CONNOR MF, HALL JB: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N. Engl. J. Med. (2000) 342:1471-1477. •• A landmark, randomised study that showed daily interruption of sedation to allow medical ICU patients to awaken shortened ventilation and ICU stay, and reduced ICU complications, regardless of whether the sedative was midazolam or propofol. (Pubitemid 30318270)
63. KRESS JP, POHLMAN AS, HALL JB: Effects of sedation interruption in critically ill, mechanically ventilated patients receiving midazolam or propofol. J. Clin. Outcomes Manag. (2001) 8:33-39. (Pubitemid 33280388)
64. CARSON SS, KRESS JP, RODGERS JE et al.: A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit. Care Med. (2006) 34(5):1326-1332. • A randomised study that showed daily interruption of sedation to allow medical ICU patients to awaken shortened ventilation and ICU stay with propofol, but not with scheduled intermittent lorazepam. (Pubitemid 43754551)
65. LEHMKUHL P, PICHLMAR I: Intensive care sedation with propofol or midazolam infusions. J. Drug Dev. (1991) 4(Suppl.):72-73.
66. PAVEL C, NICOLAU M, INONICA M, TULBRE D, GRINTESCU I: A comparative study propofol versus midazolam in long term sedation for multiple trauma patients who need assisted ventilation. Br. J. Anaesth. (1999) 82(Suppl.):164. Abstract.
67. SANCHEZ-IZQUIERDO-RIERA JA, CABALLERO-CUBEDO RE, PEREZ-VELA JL, AMBROS-CHECA A, CANTALAPIEDRA-SANTIAGO JA, ALTED-LOPEZ E: Propofol versus midazolam: safety and efficacy for sedating severe trauma patient. Anesth. Analg. (1998) 86:1219-1224. (Pubitemid 28249240)
68. SANDIUMENGE CAMPS A, SANCHEZ-IZQUIERDO RIERA JA, VAZQUEZ DT, SA BORGES M, RODRIGUEZ JP, LOPEZ EA: Midazolam and 2% propofol on long-term sedation of traumatized, critically ill patients: efficacy and safety comparison. Crit. Care Med. (2000) 28:3612-3619. (Pubitemid 30948999)
69. CERNAIANU AC, DELROSSI AJ, FLUM DR et al.: Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicentre study of hemodynamics, oxygen transport, efficacy, and cost. Crit. Care Med. (1996) 24:222-228. (Pubitemid 26065328)
70. BARR J, ZOMORODI K, BERTACCINI EJ, SHAFER SL, GELLER E: A double-blind, randomized comparison of IV lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology (2001) 95:286-298. • A randomised study of target-controlled sedation in a surgical ICU that found this method of administration is feasible for both agents, with goal sedation achieved in 49% of lorazepam patients and 69% of midazolam patients. (Pubitemid 32720715)
71. POHLMAN AS, SIMPSON KP, HALL JB: Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit. Care Med. (1994) 22:1241-1247. • A randomised study of lorazepam and midazolam for long-term sedation in a medical ICU, which found more rapid awakening with lorazepam. (Pubitemid 24244830)
72. ZOMORODI K, BERTACCINI E, BARR J, SHAFER S, GELLER E: Midazolam versus lorazepam for short term sedation in critically ill patients - a double blind study. Crit. Care Med. (1998) 26:A23. Abstract. (Pubitemid 128778236)
73. MANLEY NM, FITZPATRICK RW, LONLG T, JONES PW: A cost analysis of alfentanil + propofol versus morphine + midazolam for the sedation of critically ill patients. Pharmacoeconomics (1997) 12:247-255. • A randomised study of mixed ICU patients that found using a regimen with short-acting agents (propofol/alfentanil) shortened extubation time and length of ICU stay, and provided cost savings compared with a regimen that contained long-acting agents (midazolam/morphine). (Pubitemid 27385446)
74. POPOVICH MC, KUKREJA NR, WOLETZ J, QURESHI Z, MASCHA EJ: Prospective, randomized clinico-economic comparison of three sedation regimens in critically-ill, intubated general ICU patients. Anaesthesiology (1999) 91:A300. Abstract.
75. PLAINER B, WEINSTABL C, SPISS CK, RICHLING B, ALOY A: Propofol versus midazolam in combination with sufentanil for continuous sedation in the neurosurgical ICU. J. Drug Dev. (1989) 2(Suppl.):101-103. (Pubitemid 20045020)
76. JASTRZEBSKI J, GASZYNSKI A, GACA M et al.: Propofol versus midazolam in sedation of critically ill patients: the multicenter randomized study. Intensive Care Med. (1995) 21(Suppl.):S170. Abstract.
77. MCNULTY SE, GRATCH D, COSTELLO D, HEROPOULOS M, YUN KIM J: The effect of midazolam and lorazepam on postoperative recovery after cardiac surgery. Anesth. Analg. (1995) 81:404-407.
78. SHERRY KM, MCNAMARA J, BROWN JS, DRUMMOND M: An economic evaluation of propofol/fentanyl compared with midazolam/fentanyl on recovery in the ICU following cardiac surgery. Anaesthesia (1996) 51:312-317. (Pubitemid 26122990)
79. GODET G, GOSSENS S, PRAYSSAC P et al.: Infusion of propofol, sufentanil, or midazolam for sedation after aortic surgery: comparison of oxygen consumption and hemodynamic stability. Anesth. Analg. (1998) 87:272-276. (Pubitemid 28369076)
80. KOX W, BYRON C: Effect of sedation with alfentanil, midazolam, and propofol on oxygen transport variables in the critically ill. Br. J. Anaesth. (1990) 65:278. Abstract.
81. WAHR JA, PLUNKETT JJ, RAMSAY JG et al.: Cardiovascular responses during sedation after coronary revascularization - incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam. Anesthesiology (1996) 84:1350-1360. (Pubitemid 26192043)
82. HARRIS CE, GROUNDS RM, MURRAY AM, LUMLEY J, ROYSTON D, MORGAN M: Propofol for long-term sedation in the intensive care unit: a comparison with papaveretum and midazolam. Anaesthesia (1990) 45:366-372. (Pubitemid 20149919)
83. TREGGIARI-VENZI M, BORGEAT A, FUCHS-BUDER T, GACHOUD JP, SUTER PM: Overnight sedation with midazolam or propofol in the ICU: effects on sleep quality, anxiety and depression. Intensive Care Med. (1996) 22:1186-1190. (Pubitemid 26405507)
84. RIKER RR, FRASER GL: Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy (2005) 25(Suppl.):8S-18S. (Pubitemid 40604874)
85. MACLAREN R, SULLIVAN PW: Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients. Pharmacotherapy (2005) 25:1319-1328. •• Decision-analytical model that incorporated costs of several sedative specific adverse events and found that propofol, midazolam and lorazepam were the least-expensive sedative for short-, intermediate-, and long-term sedation, respectively. (Pubitemid 41407628)
86. MCKEAGE K, PERRY CM: Propofol: a review of its use in intensive care sedation of adults. CNS Drugs (2003) 17:235-272. (Pubitemid 36390410)
87. DEVLIN JW, LAU AK, TANIOS MA: Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy (2005) 25:1348-1352. (Pubitemid 41407632)
88. HELMY SAK, AL-ATTIYAH RJ: The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia (2001) 56:4-8. (Pubitemid 32111865)
89. MARIK PE: Propofol: an immunomodulating agent. Pharmacotherapy (2005) 25(Suppl.):28S-33S.
90. KOLLEFF MH, LEVY NT, AHRENS TS, SCHAFF R, PRENTICE D, SHERMAN G: The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest (1998) 114:541-548. • A prospective, observational cohort study that used multivariate regression analysis and found the administration of continuous sedation was associated with longer ventilator requirement, ICU stay, and hospital stay than intermittent administration. (Pubitemid 28387536)
91. PANDHARIPANDE P, SHINTANI A, PETERSON J et al.: Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology (2006) 104:21-26. • A prospective, observational cohort study that used multivariate regression analysis and found the administration of lorazepam was an independent risk factor for the development of delirium. Other sedatives and analgesics were not significantly associated with the onset of delirium, likely to be due to infrequent use compared with lorazepam.
92. ELY EW, MARGOLIN R, FRANCIS J et al.: Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU). Crit. Care Med. (2001) 29:1370-1379. (Pubitemid 32641799)
93. TAKEUCHI T, MATSUSHIMA E, MORIYA H, SHINTANI M, NAKAMURA S: Delirium in inpatients with respiratory diseases. Psychiatry Clin. Neurosci. (2005) 59:253-258. (Pubitemid 40897195)
94. RINCON HG, GRANADOS M, UNUTZER J et al.: Prevalence, detection and treatment of anxiety, depression, and treatment in the adult critical care unit. Psychosomatics (2001) 42:391-396. (Pubitemid 33032111)
95. ELY EW, INOUYE SK, BERNARD et al.: Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA (2001) 286:2703-2710. (Pubitemid 33135077)
96. MILBRANDT EB, DEPPEN S, HARRISON PL et al.: Costs associated with delirium in mechanically ventilated patients. Crit. Care Med. (2004) 32:955-962. (Pubitemid 38471515)
97. ELY EW, GAUTAM S, MARGOLIN R et al.: The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. (2001) 27:1892-1900 (Pubitemid 33145075)
98. KORAK-LEITER M, LIKAR R, OHER M et al.: Withdrawal following sufentanil/propofol and sufentanil/midazolam. Intensive Care Med. (2005) 31:380-387.
99. BROWN C, ALBRECHT R, PETTIT H, MCFADDEN T, SCHERMER C: Opioid and benzodiazepine withdrawal syndrome in adult burn patients. Am. Surg. (2000) 66:367-371. (Pubitemid 30210751)
100. CAMMARANO WB, PITTET JF, WEITZ S, SCHLOBOHM RM, MARKS JD: Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit. Care Med. (1998) 26:676-684. (Pubitemid 28201413)
101. SHAFER A: Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit. Care Med. (1998) 26:947-956. (Pubitemid 28211408)
102. YAUCHER NE, FISH JT, SMITH HW, WELLS JA: Propylene glycol-associated toxicity from lorazepam infusion. Pharmacotherapy (2003) 23:1094-1099. (Pubitemid 37158777)
103. ARROLIGA AC, SHEHAB N, MCCARTHY K, GONZALES JP: Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit. Care Med. (2004) 32:1709-1714. (Pubitemid 39050522)
104. WILSON KC, REARDON C, THEODORE AC, FARBER HW: Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest (2005) 128:1100-1101. (Pubitemid 41324463)
105. BHANA N, GOA KL, MCCLELLAN KJ: Dexmedetomidine. Drugs (2000) 59:263-268.
106. SHEHABI Y, RUETTIMANN U, ADAMSON H, INNES R, ICKERINGILL M: Dexmedetomidine infusion for more that 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med. (2004) 30:2188-2196. (Pubitemid 40174254)
107. DASTA JF, KANE-GILL SL, DURTSCHI AJ: Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann. Pharmacother. (2004) 38:1130-1135. (Pubitemid 38802147)
108. RIKER RR, FRASER GL, COX PM: Continuous infusion of haloperidol controls agitation in critically ill patients. Crit. Care Med. (1994) 22:433-440. (Pubitemid 24085295)
109. SKROBIK YK, BERGERON N, DUMONT M, GOTTFRIED ST: Olanzapine versus haloperidol: treating delirium in a critical care setting. Intensive Care Med. (2004) 30:444-449. (Pubitemid 38375619)
110. MILBRANDT EB, KERSTEN A, KONG L et al.: Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit. Care Med. (2005) 33:226-229. • A retrospective cohort analysis of mixed ICU patients that used multivariate analysis and found that haloperidol use was an independent factor for reducing hospital mortality. (Pubitemid 40116563)
111. DAHABA AA, GRABNER T, REHAK PH, LIST WF, METZLER H: Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients. Anesthesiology (2004) 101:640-646.
112. MUELLEJANS B, LOPEZ A, CROSS MH, BONOME C, MORRISON L, KIRKHAMAJT: Remifentanil versus fentanyl for analgesia based sedation to provide comfort in the intensive care unit: a randomized, double-blind controlled study. Critical Care (2004) 8:R1-R11.
113. ANGELINI G, KETZLER JT, COURSIN DB: Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. Crit. Care Clinics (2001) 17:863-880. (Pubitemid 33101685)
114. GUILLOU N, TANGUY M, SEGUIN P, BRANGER B, CAMPION J, MALLEDANT Y: The effects of small-dose ketamine on morphine consumption in surgical intensive care unit patients after major abdominal surgery. Anesth. Analg. (2003) 97:843-847. (Pubitemid 37046457)
115. MEISER A, SIRTL C, BELLGARDT et al.: Desflurane compared with propofol for postoperative sedation in the intensive care unit. Br. J. Anaesth. (2003) 90:273-280. (Pubitemid 36304865)
116. SACKEY PV, MARTLING C, GRANATH F, RADELL PJ: Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit. Care Med. (2004) 32:2241-2246. (Pubitemid 39491803)
117. BEDI A, MURRAY JM, DINGLEY J, STEVENSON MA, FEE JP: Use of xenon as a sedative for patients receiving critical care. Crit. Care Med. (2003) 31:2470-2477. (Pubitemid 37281731)
118. KONK KL, WILLATTS SM, PRYS-ROBERTS C: Isoflurane compared with midazolam for sedation in the intensive care unit. Br. Med. J. (1989) 298:1277-1280. (Pubitemid 19129162)
119. SPENCER EM, WILLATTS SM: Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med. (1992) 18:415-421. (Pubitemid 23009488)
120. MEISER A, LAUBENTHAL H: Inhalational anaesthetics in the ICU: theory and practice on inhalational sedation in the ICU, economics, risk-benefit. Best Pract. Res. Clin. Anaesthesiol. (2005) 19:523-538. (Pubitemid 40753816)
121. CLARK F, GILBERT HC: Regional analgesia in the intensive care unit: principles and practice. Crit. Care Clin. (2001) 14:943-966. (Pubitemid 33101689)
122. OSTERMANN ME, KEENAN SP, SEIFERLING RA, SIBBALD WJ: Sedation in the intensive care unit: a systemic evaluation. JAMA (2000) 283:1451-1459. (Pubitemid 30151824)
123. WALDER B, ELIA N, HENZI I, ROMAND JR, TRAMER MR: A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systemic review. Anesth. Analg. (2001) 92:975-983. • A systematic review of midazolam and propofol, which found that the agents are similar in terms of sedation quality. (Pubitemid 32239144)
124. COUGHLIN MT, ANGUS MC: Economic evaluation of new therapies in critical illness. Crit. Care Med. (2003) 31(Suppl.):S7-S16. (Pubitemid 36143472)
125. HEYLAND DK, GAFNI A, KERNERMAN P, KEENAN S, CHALFIN D: How to use the results of an economic evaluation. Crit. Care Med. (1999) 27:1195-1202 (Pubitemid 29314335)
126. CRYSTAL T, MIRANDA RJ, HAWES MR, DARYANANI AA, COPPER BP, BEATTIE KA: Cost effectiveness analysis of lorazepam versus midazolam in sedation of mechanically ventilated patients in the ICU. Proceedings of the 2001 American Society of Health-System Pharmacists Midyear Clinical Meeting - 2 December, New Orleans, LA, USA (2001) 36:576E. Abstract.
127. BARR J, EGAN TD, SANDOVAL NF et al.: Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology (2001) 95:324-333. (Pubitemid 32720719)
128. SAITO M, TERAO Y, FUKUSAKI MAKITA T, SHIBATA O, SUMIKAWA K: Sequential use of midazolam and propofol for long-term sedation in postoperative mechanically ventilated patients. Anesth. Analg. (2003) 96:834-838. • A randomised study of midazolam or sequential therapy of midazolam to propofol in a surgical ICU, which found that sequential therapy was associated with faster extubation and less agitation. (Pubitemid 36245577)
129. CIGADA M, PEZZI A, DI MAURO P. et al.: Sedation in the critically ill ventilated patient: possible role of enteral drugs. Intensive Care Med. (2005) 31:482-486.
130. LUGO RA, CHSTER EA, CASH J, GRANT MJC, VERNON DD: A cost analysis of enterally administered lorazepam un the pediatric intensive care unit. Crit. Care Med. (1999) 27:417-421. (Pubitemid 29113555)
131. SCHWEICKERT WD, GEHLBACH BK, POHLMAN AS, HALL JB, KRESS JP: Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit. Care Med. (2004) 32:1272-1276. (Pubitemid 38738578)
132. KRESS JP, GEHLBACH BK, LACY M, PLISKIN N, POHLMAN AS, HALL JB: The long-term psychological effects of daily sedative interruption on critically ill patients. Am. J. Respir. Crit. Care Med. (2003) 168:1457-1461. (Pubitemid 38037329)
133. DEVLIN JW, FRASER GL, KANJI S, RIKER RR: Sedation assessment in critically ill adults. Ann. Pharmacother. (2001) 35:1624-1632. (Pubitemid 34027466)
134. WATSON BD, KANE-GILL SL: Sedation assessment in critically ill adults: 2001-2004 update. Ann. Pharmacother. (2004) 38:1898-1906
135. DE LEMOS J, FOSTER D, CHITTOCK DR: Does using a sedation scale reduce the duration of mechanical ventilation in the critically ill: a prospective, randomized, controlled trial. Crit. Care Med. (2005) 33:12(Suppl.):A177. Abstract.
136. LEBLANC JM, DASTA JF, KANE-GILL SL: Role of bispectral index in sedation monitoring in the ICU. Ann. Pharmacother. (2006) 40:490-500.
137. FRASER GL, RIKER RR: Bispectral index monitoring in the intensive care unit provides more signal than noise. Pharmacotherapy (2005) 25(Suppl.):19S-27S. (Pubitemid 40604875)
138. DEVLIN JW, HOLBROOK AM, FULLER HD: The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann. Pharmacother. (1997) 31:689-695. (Pubitemid 27242374)
139. ADAM C, ROSSER D, MANJI M: Impact of introducing a sedation management guideline in intensive care. Anesthesia (2006) 61:260-263. (Pubitemid 43337366)
140. HADBAVNY AM, HOYT JW: Promotion of cost-effective benzodiazepine sedation. Am. J. Hosp. Pharm. (1993) 50:660-661. (Pubitemid 23096748)
141. TIMM EG, DEBLOCK HF, MITCHELL AL et al.: The development, implementation, and economic impact of a standardized adult sedation prescribing protocol in a surgical intensive care unit. Crit. Care Med. (1999) 27(Suppl.):A28. Abstract.
142. BOBEK MB, HOFFMAN-HOGG L, BAIR N, ARROIGA A, WIEDEMANN H: Implementation and cost savings of sedation guidelines in a medical intensive care unit. Crit. Care Med. (1998) 26(Suppl.):A99. Abstract. (Pubitemid 128778495)
143. BROERING B, BRENTON C, MESSICK WJ, THOMASON M: Cost-effective management of agitation in the mechanically ventilated trauma patient using sedation guidelines. Crit. Care Med. (1998) 26(Suppl.):A94. Abstract.
144. GUPTA V: Development and implementation of guidelines for management of sedation and agitation in critically ill patients. Pharm. Pract. Manage. Q (1999) 19:19-27.
145. Guidelines created for ICU sedative use. Formulary (1998) 33:592,595.
146. ROHRS CS, TU A: Initiation of a nursing-managed sedation protocol for mechanically ventilated patients in the intensive care unit (ICU): implementation and cost savings after 1 year. Crit. Care Med. (2000) 28(Suppl.):A123. Abstract.
147. MICEK S, BARNES BJ, GRAUER DW, JOHNSON DC: Long-term sedation with protocol-directed midazolam and lorazepam: a cost-effectiveness analysis. Crit. Care Med. (2004) 32(Suppl.):A174. Abstract.
148. MACLAREN R, PLAMONDON JM, RAMSAY KB, ROCKER GM, PATRICK WD, HALL RI: A prospective evaluation of empiric versus protocol-based sedation and analgesia. Pharmacotherapy (2000) 20:662-672. • Prospective study that found protocol-guided sedation and analgesia reduced drug costs and assessments of undersedation and pain. (Pubitemid 30387683)
149. MASCIA MF, KOCH M, MEDICIS JJ: Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit. Care Med. (2000) 28:2300-2306. • This prospective study also found that protocol-guided sedation and analgesia reduced drug costs and shortened ventilation and ICU stay. (Pubitemid 30604431)
150. BROOK AD, AHRENS TS, SCHAIFF R et al.: Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit. Care Med. (1999) 27:2609-2615. • Randomised study that found protocol-guided sedation shortened ventilation and ICU stay and reduced the need for tracheostomies. (Pubitemid 30027169)
151. BAIR N, BOBECK MB, HOFFMAN-HOGG L, MION LC, SLOMKA J, ARROLIGA AC: Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: physician and nurse adherence. Crit. Care Med. (2000) 28:707-713. • Prospective study of a protocol that preferentially used opioids and intermittent lorazepam, and found shorter ICU stay and reduced need for physical restraints with the protocol. (Pubitemid 30174267)
152. DE JONGHE B, BASTUJI-GARIN S, FANGIO P et al.: Sedation algorithm in critically ill patients without acute brain injury. Crit. Care Med. (2005) 33:120-127. • Prospective study of a protocol that used midazolam and fentanyl according to patient assessments and found less drug use, faster awakening, shorter ventilation and fewer pressure sores with the protocol. (Pubitemid 40116546)
153. DAVIS DA, TAYLOR-VAISEY A. Translating guidelines into practice - a systematic review of the theoretic concepts, practical experiences and research evidence in the adoption of clinical practice guidelines. CMAJ (1997) 157:408-416. (Pubitemid 27384745)
154. http://www.x-rates.com Exchange rates. Accessed July 26, 2006.
155. http://www.pharmacotherapy.org/pdf/ACCP-Spring-Abstracts-2006.pdf#search= %22Does%20Adjunctive%20Dexmedetomidine%20Therapy%20Impact%20Sedation%2 FAnalgesia%20Requirements%20to%20Facilitate%20Extubation%22 FORREST L, KISER T, MACLAREN R: Does Adjunctive Dexmedetomidine Therapy Impact Sedation/Analgesia Requirements to Facilitate Extubation? American College of Clinical Pharmacy 2006 Spring Practice and Research Forum, abstracts, p8. Accessed September 2006.